MAPK1 and breast carcinoma: Additionally, miR-145-5p downregulates SENP2 expression in breast cancer cells, enhancing ERK2 SUMOylation and selectively inhibiting cancer cell proliferation and metastasis (Figs. 4, 5, 6 and 7).